Variant report

Variant	rs55822642
Chromosome Location	chr6:26321668-26321669
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr6:26317773..26322423-chr6:26326646..26329657,4	MCF-7	breast:
2	chr6:26319791..26322184-chr6:26520367..26521947,2	K562	blood:
3	chr6:26321606..26324992-chr6:26518176..26520933,3	K562	blood:
4	chr16:57480084..57480953-chr6:26321593..26322348,2	Hela-S3	cervix:

Variant related genes	Relation type
ENSG00000199289	Chromatin interaction

Extended variants
information (count: 12 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1029920	chr6:25638507-26585842	Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1215 gene(s)	inside rSNPs	diseases
2	nsv538162	chr6:25638507-26585842	Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1215 gene(s)	inside rSNPs	diseases
3	nsv1030351	chr6:25813178-26352046	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	1189 gene(s)	inside rSNPs	diseases
4	nsv1023453	chr6:25853830-26528250	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1201 gene(s)	inside rSNPs	diseases
5	nsv428137	chr6:25987413-26351920	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	1181 gene(s)	inside rSNPs	diseases
6	nsv1015782	chr6:26026870-26323895	Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	1114 gene(s)	inside rSNPs	diseases
7	nsv1018665	chr6:26026870-26352046	Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	1116 gene(s)	inside rSNPs	diseases
8	nsv601173	chr6:26239404-26322524	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	184 gene(s)	inside rSNPs	diseases
9	nsv482729	chr6:26291011-26470898	Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	45 gene(s)	inside rSNPs	diseases
10	nsv525347	chr6:26313348-26322985	Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	11 gene(s)	inside rSNPs	diseases
11	nsv969357	chr6:26321434-26323580	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	6 gene(s)	inside rSNPs	diseases
12	nsv5230	chr6:26321593-26361531	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	32 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:55 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26314200-26321800	Weak transcription	NH-A	brain
2	chr6:26314200-26322000	Weak transcription	Right Atrium	heart
3	chr6:26314400-26322000	Weak transcription	Primary T killer memory cells from peripheral blood	blood
4	chr6:26314400-26322200	Weak transcription	Placenta Amnion	Placenta Amnion
5	chr6:26318600-26323400	Active TSS	ES-I3 Cell Line	embryonic stem cell
6	chr6:26318800-26323200	Active TSS	H9 Cell Line	embryonic stem cell
7	chr6:26319000-26322800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
8	chr6:26319000-26323000	Active TSS	H1 Cell Line	embryonic stem cell
9	chr6:26319000-26323000	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
10	chr6:26319400-26321800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr6:26320400-26322000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
12	chr6:26320600-26321800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr6:26320600-26321800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr6:26320600-26322000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr6:26320800-26321800	Flanking Active TSS	Dnd41	blood
16	chr6:26321000-26321800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
17	chr6:26321000-26322000	Enhancers	Primary T helper naive cells from peripheral blood	blood
18	chr6:26321000-26322200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr6:26321200-26321800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
20	chr6:26321200-26321800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
21	chr6:26321200-26321800	Bivalent Enhancer	Primary T cells from cord blood	blood
22	chr6:26321200-26321800	Enhancers	Primary T cells fromperipheralblood	blood
23	chr6:26321200-26321800	Enhancers	Primary T helper cells PMA-I stimulated	--
24	chr6:26321200-26322000	Bivalent Enhancer	Primary B cells from cord blood	blood
25	chr6:26321200-26322000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
26	chr6:26321200-26322000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
27	chr6:26321200-26323000	Active TSS	HUVEC	blood vessel
28	chr6:26321200-26323800	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr6:26321400-26321800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
30	chr6:26321400-26321800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
31	chr6:26321400-26321800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr6:26321400-26322000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
33	chr6:26321400-26322000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
34	chr6:26321400-26322000	Enhancers	Primary T helper cells fromperipheralblood	blood
35	chr6:26321400-26322000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
36	chr6:26321400-26322000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
37	chr6:26321400-26322800	Active TSS	NHLF	lung
38	chr6:26321400-26323000	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr6:26321400-26323000	Active TSS	HMEC	breast
40	chr6:26321400-26323200	Active TSS	HepG2	liver
41	chr6:26321400-26323400	Active TSS	GM12878-XiMat	blood
42	chr6:26321400-26323600	Active TSS	HUES6 Cell Line	embryonic stem cell
43	chr6:26321600-26322000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
44	chr6:26321600-26323000	Active TSS	Primary hematopoietic stem cells short term culture	blood
45	chr6:26321600-26323000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr6:26321600-26323000	Active TSS	NHDF-Ad	bronchial
47	chr6:26321600-26323000	Active TSS	NHEK	skin
48	chr6:26321600-26323200	Active TSS	iPS-15b Cell Line	embryonic stem cell
49	chr6:26321600-26323200	Active TSS	Hela-S3	cervix
50	chr6:26321600-26323200	Active TSS	K562	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links